| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9327293 | Gynecologic Oncology | 2005 | 9 Pages |
Abstract
High level of EphA2 protein expression is significantly associated with a shorter patient survival and EphA2 receptor is a valuable prognostic marker for ovarian carcinoma.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Liping Han, Ziming Dong, Yuhuan Qiao, Gunnar B. Kristensen, Ruth Holm, Jahn M. Nesland, Zhenhe Suo,